| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.081 | 0.1 |